Critical Care Labs Study Notes: Comprehensive

In the ICU, critically ill patients require extensive lab testing to guide diagnosis and treatment. These lab values help assess:

• Electrolyte balance

• Renal and hepatic function

• Acid-base status

• Overall metabolic stability

However, lab results must always be interpreted in clinical context, abnormal values are only meaningful when correlated with the patient’s overall condition.

Metabolic Panels

Two Types:

1. BMP (Basic Metabolic Panel) – “Chem 8”

   • Focuses on electrolytes and kidney function

2. CMP (Comprehensive Metabolic Panel)

   • Includes BMP + liver function tests

Both are collected in the green-top tube (heparinized plasma).

The Result Skeleton

Commonly used to visualize lab results:

Cations (+)	Anions (–)	Kidney Function	Glucose
Na⁺	Cl⁻	BUN	Glucose
K⁺	CO₂ (HCO₃⁻)	Creatinine	—

Key Electrolytes in the Chem 8

1. Sodium (Na⁺)

• Normal: 135–145 mEq/L

• Major extracellular ion — maintains serum osmolality & fluid balance

Abnormalities:

• Hypernatremia (>145) → dehydration, DKA, Cushing’s

  • Symptoms: Confusion, seizures, coma

  • Treatment: Gradual correction (↓ Na⁺ by 0.5–1 mEq/hr)

• Hyponatremia (<130) → SIADH, CHF, renal failure

  • Symptoms: Headache, lethargy, seizures

  • Treatment: Slow correction; if seizures → faster (2–4 mEq/hr)

2. Potassium (K⁺)

• Normal: 3.5–5.0 mEq/L

• Key roles: Cardiac rhythm, muscle contraction, nerve transmission

• Inverse relationship with pH and Na⁺

Abnormalities:

• Hyperkalemia (>6) → renal failure, acidosis, Addison’s

  • ECG: Peaked T waves

  • Treatment: Calcium gluconate/chloride, insulin + glucose, bicarb, dialysis

• Hypokalemia (<3.5) → diuretics, GI loss, alkalosis

  • ECG: U waves, flattened T waves

  • Treatment: Potassium replacement

3. Calcium (Ca²⁺)

• Normal: 8.5–10.5 mg/dL

• Most abundant mineral — essential for muscle contraction & nerve signaling

Abnormalities:

• Hypercalcemia (>10.5) → hyperparathyroidism, malignancy

  • Symptoms: Weakness, confusion, arrhythmias

  • Treatment: IV fluids, loop diuretics

• Hypocalcemia (<8.5) → hypoparathyroidism, low Mg, post-thyroidectomy

  • Symptoms: Tetany, paresthesia, seizures

  • Treatment: Calcium gluconate/chloride

4. Chloride (Cl⁻)

• Normal: 95–105 mEq/L

• Maintains acid-base balance (inverse to bicarbonate)

Abnormalities:

• Hyperchloremia: Excess saline → metabolic acidosis

• Hypochloremia: GI loss or dilution → metabolic alkalosis

5. Bicarbonate / CO₂

• Normal: 23–29 mEq/L

• Reflects metabolic component of acid-base balance

Interpretation:
↓ HCO₃⁻ = metabolic acidosis
↑ HCO₃⁻ = metabolic alkalosis

6. Blood Urea Nitrogen (BUN)

• Normal: 6–20 mg/dL

• Reflects renal perfusion and protein metabolism

↑ BUN → renal failure, dehydration
↓ BUN → liver disease, overhydration

7. Creatinine

• Normal: 0.8–1.3 mg/dL

• Most specific indicator of kidney function

↑ = renal impairment
↓ = low muscle mass or cachexia

8. Glucose

• Normal: 65–110 mg/dL

• Critical for metabolic energy balance

↑ = stress, diabetes, steroid use
↓ = insulin overdose, sepsis, liver failure

CMP (Comprehensive Metabolic Panel)

Includes all BMP components plus liver function tests:

Test	Normal Range	Significance
Alkaline Phosphatase	20–130 U/L	Biliary obstruction, bone disease
AST (SGOT)	5–30 U/L	Liver injury, muscle breakdown
ALT (SGPT)	5–30 U/L	Liver injury (specific)
Bilirubin	0.2–1.9 mg/dL	Liver/gallbladder dysfunction
Total Protein	6.3–7.9 g/dL	Nutrition, liver function
Albumin	3.4–5.4 g/dL	Oncotic pressure, chronic liver disease

Additional Important Electrolytes

Electrolyte	Normal Range	Key Points
Ionized Calcium	4.5–5.6 mg/dL (1.1–1.3 mmol/L)	50% bound to albumin; low albumin → false low total Ca²⁺
Phosphorus (PO₄³⁻)	3–4.5 mg/dL	Inverse relationship with Ca²⁺; ↑ in renal failure
Magnesium (Mg²⁺)	1.5–2.0 mEq/L	Regulates neuromuscular excitability; deficiency → Torsades de Pointes

Abnormalities:

• Hypermagnesemia (>2.2) → renal failure; ↓ DTRs, bradycardia, hypotension

• Hypomagnesemia (<1.2) → alcohol abuse, GI loss; tremors, seizures, arrhythmias

The Clinical Takeaways

• Always interpret lab values within the patient’s overall context — not in isolation.

• Test with purpose: Only order labs that will guide treatment.

• ICU nurses play a vital role in:

  • Collecting and verifying samples

  • Recognizing critical values early

  • Notifying providers promptly

  • Implementing corrective interventions

The Key Highlights

• BMP = electrolytes + renal function

• CMP = BMP + liver panel

• Na⁺, K⁺, Ca²⁺, Cl⁻, HCO₃⁻ = cornerstone electrolytes for ICU monitoring

• Interpret in context: lab data + clinical picture = safe critical care

• Correct slowly: rapid correction of sodium or calcium can be dangerous

Care Study Notes: Coagulation Studies:

Coagulation disorders (bleeding or clotting abnormalities) are common in critically ill patients. Causes range from liver failure, DIC (disseminated intravascular coagulation), to therapeutic anticoagulation for devices or procedures (e.g., LVAD, Impella, ECMO, CRRT).
Understanding coagulation studies helps ensure:

• Proper diagnosis of underlying pathology

• Safe and effective monitoring of anticoagulant therapy

The Coagulation Process

Coagulation (clotting) is the transformation of blood from a liquid to a gel to stop bleeding and achieve hemostasis.
It involves four main stages:

1. Vasoconstriction – narrowing of blood vessels

2. Platelet plug formation – temporary hemostatic plug

3. Activation of the clotting cascade – intrinsic, extrinsic, and common pathways

4. Fibrin clot formation – stable fibrin mesh seals the vessel

Pathways

• Intrinsic Pathway: Triggered by vessel injury within the blood; slower, complex

• Extrinsic Pathway: Triggered by external trauma (tissue factor release); faster

• Common Pathway: Final stage where both meet → fibrin clot formation

Major Coagulation Tests

Test	Pathway Assessed	Main Factors Evaluated	Normal Range	Critical Values	Notes
PTT / aPTT	Intrinsic & Common	I, II, V, VIII, IX, X, XI, XII	PTT: 60–70 sec; aPTT: 30–40 sec	>100 sec	Monitors heparin therapy; prolonged by liver disease, vitamin K deficiency, anticoagulation
PT / INR	Extrinsic & Common	II, V, VII, X	PT: 9.5–13.5 sec; INR: 0.8–1.1	INR >5	Monitors warfarin therapy; prolonged in liver disease, vitamin K deficiency, DIC
Fibrinogen (Factor I)	Common	Fibrinogen level	200–400 mg/dL	<100 mg/dL	↓ in DIC, liver disease, large transfusion; ↑ in trauma, inflammation, cancer
Anti-Xa	Anticoagulant Monitoring	Factor Xa inhibition	Therapeutic: 0.6–1.3 IU/mL	—	Used to monitor heparin or LMWH therapy effectiveness
ACT (Activated Clotting Time)	Whole Blood Clotting	Overall clotting function	70–120 sec	—	Used during procedures (e.g., bypass, ECMO); therapeutic goal 150–600 sec
TEG (Thromboelastography)	Global Coagulation	All clotting components	Variable	—	Provides dynamic view of clot formation, strength, and breakdown
D-Dimer	Fibrinolysis	Fibrin degradation product	<500 ng/mL	—	↑ indicates clot breakdown (DVT, PE, DIC); non-specific test

Detailed Discussion of Key Tests

1. PTT / aPTT (Partial Thromboplastin Time / Activated PTT)

• Purpose: Evaluates intrinsic and common pathways

• Normal:

  • PTT: 60–70 sec

  • aPTT: 30–40 sec (activator shortens test time)

• Critical: >100 sec

• Prolonged in:

  • Hemophilia (VIII, IX, XI deficiency)

  • Vitamin K deficiency

  • Liver disease

  • Heparin therapy

• Shortened in:

  • DIC

  • Severe hemorrhage

  • Cancer

2. PT / INR (Prothrombin Time & International Normalized Ratio)

• Pathway: Extrinsic & Common

• Normal: PT 9.5–13.5 sec, INR 0.8–1.1 (goal = 1.0)

• Critical: INR >5.0

• Therapeutic Range:

  • DVT, PE, A-fib: 2.0–3.0

  • Mechanical heart valve: 2.5–3.5

• Prolonged in:

  • Vitamin K deficiency

  • Liver disease

  • Warfarin therapy

  • DIC, massive transfusion

• Shortened in:

  • FFP transfusion

  • Vitamin K supplementation

• Drug interferences:

  • ↑ PT/INR: erythromycin, allopurinol

  • ↓ PT/INR: rifampin, penicillin, doxycycline, aspirin

3. Fibrinogen (Factor I)

• Role: Final substrate converted to fibrin by thrombin

• Normal: 200–400 mg/dL

• Critical: <100 mg/dL

• Increased in: Inflammation, trauma, cancer

• Decreased in: DIC, liver disease, large transfusion

• Drug interferences:

  • ↑: Salicylates

  • ↓: Statins, atenolol, prednisone

4. Anti-Factor Xa

• Measures: Effectiveness of heparin therapy (UFH or LMWH)

• Therapeutic Ranges:

  • Unfractionated heparin: 0.3–0.7 IU/mL

  • Low molecular weight heparin: 0.6–1.3 IU/mL

• No true “normal” value for non-anticoagulated patients

• Use: ICU patients on ECMO, CRRT, LVAD, Impella, or with stents

5. ACT (Activated Clotting Time)

• Use: High-dose heparin monitoring during:

  • Cardiopulmonary bypass

  • ECMO

  • Cardiac catheterization

• Normal: 70–120 sec

• Therapeutic Goal: 150–600 sec (procedure-dependent)

• Not reliable at extremely high heparin doses-switch to Anti-Xa

6. TEG (Thromboelastography)

• Purpose: Evaluates entire coagulation process dynamically, from clot initiation → strength → breakdown.

• Utility: Guides transfusion therapy in trauma, liver transplant, and cardiac surgery.

• Interpretation: Requires separate in-depth lesson due to complexity.

7. D-Dimer

• Purpose: Detects fibrin degradation products, indicating active clot breakdown.

• Normal: <500 ng/mL

• Elevated in: DVT, PE, DIC, malignancy, infection, post-op states

• Not diagnostic on its own — use with clinical suspicion & imaging.

Common ICU Scenarios

Condition	Typical Coag Findings	Notes
Liver failure	↑ PT/INR, ↑ aPTT, ↓ fibrinogen	↓ synthesis of clotting factors
DIC	↑ PT/INR, ↑ aPTT, ↓ fibrinogen, ↑ D-dimer	Consumptive coagulopathy
Heparin therapy	↑ aPTT, ↑ Anti-Xa	Monitor closely in ECMO/CRRT
Warfarin therapy	↑ PT/INR	Vitamin K antidote if excessive
Massive transfusion	↓ fibrinogen, prolonged PT/aPTT	Dilutional coagulopathy

Clinical Pearls

• Always correlate lab results with the clinical picture.

• Recheck critical values to rule out lab error before acting.

• Be aware of drug interferences that may falsely alter results.

• Monitor trends, not just single numbers — trajectory matters.

• In patients on ECMO, LVAD, Impella, or CRRT, daily coag panels are essential.

Key Normal Ranges Summary

Test	Normal Range	Critical Value
PTT	60–70 sec	>100 sec
aPTT	30–40 sec	>100 sec
PT	9.5–13.5 sec	—
INR	0.8–1.1	>5.0
Fibrinogen	200–400 mg/dL	<100 mg/dL
Anti-Xa	0.6–1.3 IU/mL (therapeutic)	—
ACT	70–120 sec (normal)	150–600 sec (therapeutic)
D-Dimer	<500 ng/mL	—

Summary

Coagulation studies are vital for ICU management.
They help detect both pathologic bleeding tendencies (like DIC, liver failure) and ensure therapeutic anticoagulation is within target range.
Every ICU nurse and clinician must know:

• Which pathway a test measures

• What affects results

• When intervention is needed

Critical Care Study Notes: Hematology & CBC Interpretation

Hematology studies are essential for evaluating the components of blood and identifying a wide range of disorders in critically ill patients.
They provide diagnostic clues and guide treatment decisions in the ICU.

Main Components of Blood:

1. Red Blood Cells (RBCs) – Carry oxygen and carbon dioxide

2. White Blood Cells (WBCs) – Fight infection and mediate immune responses

3. Platelets (PLTs) – Aid in clot formation

The Complete Blood Count (CBC)-or hemogram-is the most common and comprehensive hematology test.

1. Red Blood Cells (RBCs), Hemoglobin, and Hematocrit

Hemoglobin (Hgb)

• Definition: Iron-containing protein in RBCs responsible for oxygen and CO₂ transport.

• Normal Values:

  • Men: 14–18 g/dL

  • Women: 12–16 g/dL

↓ Low Hgb (Anemia) Causes:

• Acute or chronic bleeding (e.g., GI bleed, trauma, post-op)

• Nutrient deficiencies: Iron, B12, folate

• Hereditary disorders: Sickle cell, thalassemia

• Chronic diseases: Liver, kidney, cancer

• Medications: Chemotherapy, penicillin group, amitriptyline

↑ High Hgb Causes (Rare):

• Chronic hypoxia: COPD, smokers, fibrosis

• High altitude living

• Bone marrow disorders (polycythemia)

• Medications: Ivermectin, hydroxyurea, interferon

Hematocrit (Hct)

• Definition: % of blood volume occupied by RBCs.

• Normal Values:

  • Men: 40–50%

  • Women: 37–47%

Expected Relationship:

Hct ≈ 3 × Hgb
(e.g., Hgb 12 → Hct ≈ 36%)

Clinical Interpretations:

Hgb	Hct	Interpretation
↓	↓	Anemia, hemorrhage
N	↓	Pregnancy, overhydration
N	↑	Dehydration
↑	↑	Chronic hypoxia, COPD, altitude

Medications Affecting Hct:

• ↑ Hct: Clozapine, carvedilol, atropine

• ↓ Hct: Phenytoin, theophylline, enalapril, losartan

Red Blood Cell Count (RBC)

• Normal Values:

  • Men: 4.5–6.0 million/mm³

  • Women: 4.0–5.5 million/mm³

• Low RBC → Anemia

• High RBC → Polycythemia, chronic hypoxia

2. RBC Indices (Help Determine Type of Anemia)

Index	Definition	Normal Range	Clinical Meaning
MCV (Mean Corpuscular Volume)	Avg. RBC size	80–100 fL	↓ = Microcytic (iron deficiency) ↑ = Macrocytic (B12/Folate deficiency)
RDW (Red Cell Distribution Width)	Variability in RBC size	12–16%	↑ = Mixed population (acute bleed, deficiency)
MCH (Mean Corpuscular Hemoglobin)	Avg. Hgb per RBC	27–33 pg	↓ = Hypochromic (less Hgb per cell)
MCHC (Mean Corpuscular Hgb Concentration)	Avg. Hgb concentration	32–36 g/dL	↓ = Hypochromic anemia; N = Normochromic

3. White Blood Cells (WBCs)

• Normal Range: 4,500–10,500 cells/mm³

• Function: Immune defense and inflammation control

Condition	Interpretation
↑ WBC (Leukocytosis)	Infection, inflammation, leukemia
↓ WBC (Leukopenia)	Immunosuppression, chemo, autoimmune disease

WBC Differential (5 Types & Significance)

Cell Type	% Range	Absolute Count	↑ Elevation Seen In	↓ Decrease Seen In
Neutrophils	40–75%	1,500–8,000	Acute infection, stress	Radiation, chemo, lupus, measles
Basophils	0–2%	0–200	Leukemia, Hodgkin’s, ulcerative colitis	Pregnancy, hyperthyroid
Eosinophils	1–6%	0–600	Allergies, parasites, skin disease	Stress, trauma, Cushing’s
Lymphocytes	20–25%	1,000–4,500	TB, syphilis, autoimmune disease	CHF, renal failure, steroids
Monocytes	2–10%	0–800	Chronic infection (TB, endocarditis)	—

4. Platelets (PLTs)

• Normal Range: 150,000–300,000 /mm³

• Function: Blood clotting and wound repair

Abnormality	Name	Causes
↓ Platelets (<150k)	Thrombocytopenia	ITP, nutrient deficiency, bone marrow disease, liver/spleen dysfunction, meds (amiodarone, chemo, protonix)
↑ Platelets (>300k)	Thrombocytosis	Anemia, cancer, infection, bone marrow disorders, meds (lithium, meropenem)

Bleeding risk significantly increases when platelets < 50,000/mm³.
Platelet function (not just count) may need to be tested separately.

Clinical Relevance in ICU

• CBC guides evaluation of anemia, infection, inflammation, coagulation, and marrow function.

• Always correlate values with patient symptoms, history, and current therapies.

• Consider medication effects on counts before making clinical judgments.

• In critical patients:

  • Monitor for bleeding, infection, or marrow suppression

  • Evaluate fluid status when interpreting Hgb/Hct

  • Trend labs over time—one value is never enough

Summary Table

Test	Function	Normal Range	Key Interpretation
Hgb	O₂ transport	M: 14–18 / W: 12–16 g/dL	↓ Anemia, ↑ COPD, altitude
Hct	% RBC volume	M: 40–50 / W: 37–47%	Parallel to Hgb (3:1)
RBC	Cell count	M: 4.5–6 / W: 4–5.5 million	↓ Anemia, ↑ Polycythemia
MCV	RBC size	80–100 fL	↓ Microcytic, ↑ Macrocytic
RDW	RBC size variation	12–16%	↑ Mixed anemia
WBC	Infection marker	4.5–10.5k	↑ Infection, ↓ Immunosuppression
Platelets	Clotting	150–300k	↓ ITP, ↑ Inflammation/Cancer

Clinical Pearls

• Always compare Hgb and Hct together — they provide context for hydration and oxygenation.

• Indices (MCV, MCH, MCHC) help determine the type and cause of anemia.

• Differential WBC count pinpoints infection type (bacterial, viral, parasitic, etc.).

• Platelet count ≠ platelet function — if bleeding persists despite normal count, assess function.

• Monitor trends, not isolated values.